KETO-CTA compared high-LDL to very-high-LDL keto dieters with no low-LDL control group
Gokhan argues media coverage misrepresented KETO-CTA: it compared keto dieters with LDL around 200 to those around 300, with no low-LDL control, and still showed substantial new plaque, progressing like high-risk conditions. He says he would not keto as a lean mass hyper-responder and controls his own LDL with low-dose rosuvastatin.












